Cart summary

You have no items in your shopping cart.

Brazikumab Antibody

Brazikumab Antibody

Catalog Number: orb1980510

DispatchUsually dispatched within 5-10 working days
$ 300.00
Catalog Numberorb1980510
CategoryAntibodies
DescriptionBrazikumab (AMG 139) is a humanized antibody targeting IL-23 by binding to the P19 subunit. It is a selective IL23p19 antagonist and can be used in Crohn's disease research.
ClonalityMonoclonal
CAS Number1610353-18-8
Concentration5.98 mg/mL
Purity95.00%
ConjugationUnconjugated
TargetBrazikumab
Biological ActivityBrazikumab (AMG 139), a human IgG2 monoclonal antibody, selectively targets the p19 subunit of IL-23 with a dissociation constant (K D) of 0.138 nM, indicating high affinity for human IL-23. It is employed in Crohn's disease research [1].
StorageMaintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
NoteFor research use only
Expiration Date12 months from date of receipt.
  • Anti-IL-23 Reference Antibody (brazikumab) [orb1817854]

    ELISA,  FC

    Human

    Monoclonal

    Unconjugated

    100 μg
  • Anti-IL-23 Reference Antibody (brazikumab) [orb1805699]

    ELISA,  FA,  FACS,  Kinetics

    Human

    Monoclonal

    Unconjugated

    50 μg, 100 μg, 1 mg, 5 mg
  • Brazikumab [orb1290187]

    ELISA

    Human

    Mouse

    Monoclonal

    Unconjugated

    100 μg, 1 mg
  • Brazikumab Biosimilar(Anti-IL-23 Reference Antibody) [orb2703868]

    Monoclonal

    Unconjugated

    100 mg